Exploring immunotherapy in colorectal cancer
2022 · Journal of Hematology & Oncology · 311 citations
https://doi.org/10.1186/s13045-022-01294-4
J
Junyong Weng
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
41
Papers
1.2K
Citations
17
h-index
20
i10-index
Junyong Weng is an academic researcher from Shanghai Medical College of Fudan University. The author has contributed to research in topics: Cancer-related molecular mechanisms research & Circular RNAs in diseases & Colorectal Cancer Treatments and Studies. The author has an h-index of 17, co-authored 35 publications.
ORCID: 0000-0003-1826-3952Papers by this author
worksmiR-21 promotes EGF-induced pancreatic cancer cell proliferation by targeting Spry2
2018 · Cell Death and Disease · 102 citations
https://doi.org/10.1038/s41419-018-1182-9
RBBP6, a RING finger-domain E3 ubiquitin ligase, induces epithelial–mesenchymal transition and promotes metastasis of colorectal cancer
2019 · Cell Death and Disease · 45 citations
https://doi.org/10.1038/s41419-019-2070-7
PCDHGA9 represses epithelial-mesenchymal transition and metastatic potential in gastric cancer cells by reducing β-catenin transcriptional activity
2020 · Cell Death and Disease · 16 citations
https://doi.org/10.1038/s41419-020-2398-z
The miR-1269a/PCDHGA9/CXCR4/β-catenin pathway promotes colorectal cancer invasion and metastasis
2024 · Cellular & Molecular Biology Letters · 7 citations
https://doi.org/10.1186/s11658-024-00656-9
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat